Overview

Entire-body PET Scans for Multiple Sclerosis

Status:
Not yet recruiting

Trial end date:
2022-03-01

Target enrollment:

Participant gender:

Summary

To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.

Phase:

Early Phase 1

Details

Lead Sponsor:

Brain Health Alliance

Treatments:

Radiopharmaceuticals